The history of melanoma diagnostics

1 Ali Z, Yousaf N, Larkin J. Melanoma epidemiology, biology and prognosis. EJC Suppl. 2013;11(2):81–91; DOI:10.1016/j.ejcsup.2013.07.012. AliZ YousafN LarkinJ Melanoma epidemiology, biology and prognosis EJC Suppl 2013 11 2 81 91 10.1016/j.ejcsup.2013.07.012 Open DOISearch in Google Scholar

2 Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014;28(6):1005–11. RastrelliM TropeaS RossiCR AlaibacM Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification In Vivo 2014 28 6 1005 11 Search in Google Scholar

3 Morton DL, Essner R, Kirkwood JM, Wollman RC. History of Melanoma. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; 2003. MortonDL EssnerR KirkwoodJM WollmanRC History of Melanoma Holland-Frei Cancer Medicine 6th edition Hamilton (ON) BC Decker 2003 Search in Google Scholar

4 Urteaga O, Pack GT. On the antiquity of melanoma. Cancer. 1966;19(5):607–10; DOI:10.1002/1097-0142(196605)19:5<607::aid-cncr2820190502>3.0.co;2-8. UrteagaO PackGT On the antiquity of melanoma Cancer 1966 19 5 607 10 10.1002/1097-0142(196605)19:5<607::aid-cncr2820190502>3.0.co;2-8 Open DOISearch in Google Scholar

5 Rebecca VW, Sondak VK, Smalley KS. A brief history of melanoma: from mummies to mutations. Melanoma Res. 2013;22(2):114–22; DOI:10.1097/CMR.0b013e328351fa4d. RebeccaVW SondakVK SmalleyKS A brief history of melanoma: from mummies to mutations Melanoma Res 2013 22 2 114 22 10.1097/CMR.0b013e328351fa4d Open DOISearch in Google Scholar

6 Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019;20(11):1366–79; DOI:10.1080/15384047.2019.1640032. DavisLE ShalinSC TackettAJ Current state of melanoma diagnosis and treatment Cancer Biol Ther 2019 20 11 1366 79 10.1080/15384047.2019.1640032 Open DOISearch in Google Scholar

7 McLeod GR, Davis NC. Historical overview of melanoma. Clinics in Dermatology. 1992; 10(1):5–7; DOI:10.1016/0738-081X(92)90051-Y. McLeodGR DavisNC Historical overview of melanoma Clinics in Dermatology 1992 10 1 5 7 10.1016/0738-081X(92)90051-Y Open DOISearch in Google Scholar

8 Łopusiewicz Ł, Lisiecki S. „Czarne złoto” – melaniny w życiu człowieka. Kosmos. Problemy nauk biologicznych. 2016;65(4):621–9. ŁopusiewiczŁ LisieckiS „Czarne złoto” – melaniny w życiu człowieka Kosmos. Problemy nauk biologicznych 2016 65 4 621 9 Search in Google Scholar

9 Lane-Brown M, Roxanas MG. Laennec's melanosis: The first published description of metastatic melanoma. The Australasian Journal of Dermatology. 2017;58(3):234–5; DOI:10.1111/ajd.12492. Lane-BrownM RoxanasMG Laennec's melanosis: The first published description of metastatic melanoma The Australasian Journal of Dermatology 2017 58 3 234 5 10.1111/ajd.12492 Open DOISearch in Google Scholar

10 Mr. Fawdington on Melanosis. Med Chir Rev. 1826;5(10):335–42. Mr. Fawdington on Melanosis Med Chir Rev 1826 5 10 335 42 Search in Google Scholar

11 https://hekint.org/2020/09/28/sir-robert-carswell-illustrious-medical-illustrator/ (access: 22.11.20). https://hekint.org/2020/09/28/sir-robert-carswell-illustrious-medical-illustrator/ (access: 22.11.20). Search in Google Scholar

12 Norris W. Eight cases of melanosis: with pathological and therapeutical remarks on that disease”. London: Longman. 1857;3–13. NorrisW Eight cases of melanosis: with pathological and therapeutical remarks on that disease London Longman 1857 3 13 Search in Google Scholar

13 Pringle J. A Method of Operation in Cases of Melanotic Tumours of the Skin Edinburgh Medical Journal. 1908;23(6):496–99. PringleJ A Method of Operation in Cases of Melanotic Tumours of the Skin Edinburgh Medical Journal 1908 23 6 496 99 Search in Google Scholar

14 Neuhaus SJ, Clark MA, Thomas JM. Dr. Herbert Lumley Snow, MD, MRCS (1847–1930): The Original Champion of Elective Lymph Node Dissection in Melanoma. Ann Surg Oncol. 2004;11:875–878; DOI:10.1245/ASO.2004.02.031. NeuhausSJ ClarkMA ThomasJM Dr. Herbert Lumley Snow, MD, MRCS (1847–1930): The Original Champion of Elective Lymph Node Dissection in Melanoma Ann Surg Oncol 2004 11 875 878 10.1245/ASO.2004.02.031 Open DOISearch in Google Scholar

15 Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902–8; DOI:10.1097/00000658-197011000-00017. BreslowA Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma Ann Surg 1970 172 5 902 8 10.1097/00000658-197011000-00017 Open DOISearch in Google Scholar

16 Manchi M, Canzonieri V. Atypical melanocytic lesions: a historical overview. Pol J Pathol. 2019;70(1):26–32; DOI:10.5114/pjp.2019.84459. ManchiM CanzonieriV Atypical melanocytic lesions: a historical overview Pol J Pathol 2019 70 1 26 32 10.5114/pjp.2019.84459 Open DOISearch in Google Scholar

17 Jabłońska S, Majewski S. Choroby skóry i choroby przenoszone drogą płciową. 2010; Wydawnictwo Lekarskie PZWL:377–8. JabłońskaS MajewskiS Choroby skóry i choroby przenoszone drogą płciową 2010 Wydawnictwo Lekarskie PZWL 377 8 Search in Google Scholar

18 Gorantla VC, Kirkwood JM. State of melanoma: an historic overview of a field in transition. Hematol Oncol Clin North Am. 2014;28(3):415–35; DOI:10.1016/j.hoc.2014.02.010. GorantlaVC KirkwoodJM State of melanoma: an historic overview of a field in transition Hematol Oncol Clin North Am 2014 28 3 415 35 10.1016/j.hoc.2014.02.010 Open DOISearch in Google Scholar

19 Emri G, Paragh G, Tósaki Á, Janka E, Kollár S, Hegedűs C, Gellén E, Horkay I, Koncz G, Remenyik É. Ultraviolet radiation-mediated development of cutaneous melanoma: An update. J Photochem Photobiol B. 2018;185:169–75; DOI:10.1016/j.jphotobiol.2018.06.005. EmriG ParaghG TósakiÁ JankaE KollárS HegedűsC GellénE HorkayI KonczG RemenyikÉ Ultraviolet radiation-mediated development of cutaneous melanoma: An update J Photochem Photobiol B 2018 185 169 75 10.1016/j.jphotobiol.2018.06.005 29936410 Open DOISearch in Google Scholar

20 https://blog.labtag.com/a-brief-history-of-histology/ (access: 23.11.2020). https://blog.labtag.com/a-brief-history-of-histology/ (access: 23.11.2020). Search in Google Scholar

21 Musumeci G. Past, present and future: overview on histology and histopathology. J Histol Histopathol. 2014;1:5; DOI:10.7243/2055-091X-1-5. MusumeciG Past, present and future: overview on histology and histopathology J Histol Histopathol 2014 1 5 10.7243/2055-091X-1-5 Open DOISearch in Google Scholar

22 Haggard HW, Smith GM. Johannes Müller and the Modern Conception of Cancer. Yale J Biol Med. 1938;10(5):419.b1–436. HaggardHW SmithGM Johannes Müller and the Modern Conception of Cancer Yale J Biol Med 1938 10 5 419.b1 436 Search in Google Scholar

23 Gong HZ, Zheng HY, Li J. Amelanotic melanoma. Melanoma Res. 2019;29(3):221–30; DOI:10.1097/CMR.0000000000000571. GongHZ ZhengHY LiJ Amelanotic melanoma Melanoma Res 2019 29 3 221 30 10.1097/CMR.0000000000000571 30672881 Open DOISearch in Google Scholar

24 Rao BK, Ahn CS. Dermatoscopy for melanoma and pigmented lesions. Dermatol Clin. 2012; 30(3):413–34; DOI:10.1016/j.det.2012.04.005. RaoBK AhnCS Dermatoscopy for melanoma and pigmented lesions Dermatol Clin 2012 30 3 413 34 10.1016/j.det.2012.04.005 22800549 Open DOISearch in Google Scholar

25 Micali G, Lacarrubba F. Dermatoscopy: Instrumental Update. Dermatol Clin. 2018;36(4):345–8; DOI:10.1016/j.det.2018.05.001. MicaliG LacarrubbaF Dermatoscopy: Instrumental Update Dermatol Clin 2018 36 4 345 8 10.1016/j.det.2018.05.001 30201143 Open DOISearch in Google Scholar

26 Filosa A, Filosa G. Melanoma Diagnosis: The Importance of Histopathological Report. Dermatopathology (Basel). 2018;5(1):41–3; DOI:10.1159/000486670. FilosaA FilosaG Melanoma Diagnosis: The Importance of Histopathological Report Dermatopathology (Basel) 2018 5 1 41 3 10.1159/000486670 592095429719829 Open DOISearch in Google Scholar

27 Mishra H, Mishra PK, Ekielski A, Jaggi M, Iqbal Z, Talegaonkar S. Melanoma treatment: from conventional to nanotechnology. J Cancer Res Clin Oncol. 2018;144(12):2283–2302; DOI:10.1007/s00432-018-2726-1. MishraH MishraPK EkielskiA JaggiM IqbalZ TalegaonkarS Melanoma treatment: from conventional to nanotechnology J Cancer Res Clin Oncol 2018 144 12 2283 2302 10.1007/s00432-018-2726-1 30094536 Open DOISearch in Google Scholar

28 Zuluaga-Sepúlveda MA, Arellano-Mendoza I, Ocampo-Candiani J. Actualización en el tratamiento quirúrgico del melanoma cutáneo primario y metastásico. Cir Cir. 2016;84(1):77–84; DOI:10.1016/j.circir.2015.06.020. Zuluaga-SepúlvedaMA Arellano-MendozaI Ocampo-CandianiJ Actualización en el tratamiento quirúrgico del melanoma cutáneo primario y metastásico Cir Cir 2016 84 1 77 84 10.1016/j.circir.2015.06.020 26277601 Open DOISearch in Google Scholar

29 Broekaert SM, Roy R, Okamoto I, van den Oord J, Bauer J, Garbe C, Barnhill RL, Busam KJ, Cochran AJ, Cook MG, Elder DE, McCarthy SW, Mihm MC, Schadendorf D, Scolyer RA, Spatz A, Bastian BC. Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res. 2010;23(6):763–70; DOI:10.1111/j.1755-148X.2010.00778.x. BroekaertSM RoyR OkamotoI van den OordJ BauerJ GarbeC BarnhillRL BusamKJ CochranAJ CookMG ElderDE McCarthySW MihmMC SchadendorfD ScolyerRA SpatzA BastianBC Genetic and morphologic features for melanoma classification Pigment Cell Melanoma Res 2010 23 6 763 70 10.1111/j.1755-148X.2010.00778.x 310797320874733 Open DOISearch in Google Scholar

30 Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol. 2014;810:120–40; DOI:10.1007/978-1-4939-0437-2_7. LeiterU EigentlerT GarbeC Epidemiology of skin cancer Adv Exp Med Biol 2014 810 120 40 10.1007/978-1-4939-0437-2_7 25207363 Open DOISearch in Google Scholar

31 Colloby PS, West KP, Fletcher A. Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma. J Pathol. 1991;163(3):245–50; DOI:10.1002/path.1711630310. CollobyPS WestKP FletcherA Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma J Pathol 1991 163 3 245 50 10.1002/path.1711630310 2013827 Open DOISearch in Google Scholar

32 Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW. Immunohistochemical characteristics of melanoma. J Cutan Pathol. 2008; 35(5):433–44; DOI:10.1111/j.1600-0560.2007.00891.x. OhsieSJ SarantopoulosGP CochranAJ BinderSW Immunohistochemical characteristics of melanoma J Cutan Pathol 2008 35 5 433 44 10.1111/j.1600-0560.2007.00891.x 18399807 Open DOISearch in Google Scholar

33 Pitcovski J, Shahar E, Aizenshtein E, Gorodetsky R. Melanoma antigens and related immunological markers. Crit Rev Oncol Hematol. 2017;115:36–49; DOI:10.1016/j.critrevonc.2017.05.001. PitcovskiJ ShaharE AizenshteinE GorodetskyR Melanoma antigens and related immunological markers Crit Rev Oncol Hematol 2017 115 36 49 10.1016/j.critrevonc.2017.05.001 28602168 Open DOISearch in Google Scholar

34 Kamińska P, Buszka K, Budna-Tukan J. Wybrane metody izolacji i detekcji krążących komórek nowotworowych w różnych typach nowotworów. Post Biol Komórki. 2020;47(2):141–60. KamińskaP BuszkaK Budna-TukanJ Wybrane metody izolacji i detekcji krążących komórek nowotworowych w różnych typach nowotworów Post Biol Komórki 2020 47 2 141 60 Search in Google Scholar

35 Lin J, Li J, Huang B, Liu J, Chen X, Chen XM, Xu YM, Huang LF, Wang XZ. Exosomes: novel biomarkers for clinical diagnosis. Scientific World Journal. 2015;2015:657086; DOI:10.1155/2015/657086. LinJ LiJ HuangB LiuJ ChenX ChenXM XuYM HuangLF WangXZ Exosomes: novel biomarkers for clinical diagnosis Scientific World Journal 2015 2015 657086 10.1155/2015/657086 432285725695100 Open DOISearch in Google Scholar

36 Phallen J, Sausen M, Adleff V, Leal A, Hruban C, White J, Anagnostou V, Fiksel J, Cristiano S, Papp E, Speir S, Reinert T, Orntoft MW, Woodward BD, Murphy D, Parpart-Li S, Riley D, Nesselbush M, Sengamalay N, Georgiadis A, Li QK, Madsen MR, Mortensen FV, Huiskens J, Punt C, van Grieken N, Fijneman R, Meijer G, Husain H, Scharpf RB, Diaz LA Jr, Jones S, Angiuoli S, Ørntoft T, Nielsen HJ, Andersen CL, Velculescu VE. Direct detection of early-stage cancers using circulating tumour DNA. Sci Transl Med. 2017;9(403):eaan2415; DOI:10.1126/scitranslmed.aan2415. PhallenJ SausenM AdleffV LealA HrubanC WhiteJ AnagnostouV FikselJ CristianoS PappE SpeirS ReinertT OrntoftMW WoodwardBD MurphyD Parpart-LiS RileyD NesselbushM SengamalayN GeorgiadisA LiQK MadsenMR MortensenFV HuiskensJ PuntC van GriekenN FijnemanR MeijerG HusainH ScharpfRB DiazLAJr JonesS AngiuoliS ØrntoftT NielsenHJ AndersenCL VelculescuVE Direct detection of early-stage cancers using circulating tumour DNA Sci Transl Med 2017 9 403 eaan2415 10.1126/scitranslmed.aan2415 671497928814544 Open DOISearch in Google Scholar

37 Rapanotti MC, Campione E, Spallone G, Orlandi A, Bernardini S, Bianchi L. Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146. Cell Death Discov. 2017;3:17005; DOI:10.1038/cddiscovery.2017.5. RapanottiMC CampioneE SpalloneG OrlandiA BernardiniS BianchiL Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146 Cell Death Discov 2017 3 17005 10.1038/cddiscovery.2017.5 533752428280601 Open DOISearch in Google Scholar

38 Cayrefourcq L, De Roeck A, Garcia C, Stoebner PE, Fichel F, Garima F, Perriard F, Daures JP, Meunier L, Alix-Panabières C. S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells. Cells. 2019;8(7):755; DOI:10.3390/cells8070755. CayrefourcqL De RoeckA GarciaC StoebnerPE FichelF GarimaF PerriardF DauresJP MeunierL Alix-PanabièresC S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells Cells 2019 8 7 755 10.3390/cells8070755 667825031330795 Open DOISearch in Google Scholar

39 Paoletti C, Hayes DF. Circulating Tumour Cells. Adv Exp Med Biol. 2016;882:235–58; DOI:10.1007/978-3-319-22909-6_10. PaolettiC HayesDF Circulating Tumour Cells Adv Exp Med Biol 2016 882 235 58 10.1007/978-3-319-22909-6_10 26987538 Open DOISearch in Google Scholar

40 Nieva JJ, Kuhn P. Fluid biopsy for solid tumours: a patient's companion for lifelong characterization of their disease. Future Oncol. 2012;8(8): 989–98; DOI:10.2217/fon.12.91. NievaJJ KuhnP Fluid biopsy for solid tumours: a patient's companion for lifelong characterization of their disease Future Oncol 2012 8 8 989 98 10.2217/fon.12.91 365862522894671 Open DOISearch in Google Scholar

41 Mandel P, Metais P. Les acides nucléiques du plasma sanguin chez l’homme [Nuclear Acids In Human Blood Plasma]. C R Seances Soc Biol Fil. 1948;142(3–4):241–3. MandelP MetaisP Les acides nucléiques du plasma sanguin chez l’homme [Nuclear Acids In Human Blood Plasma] C R Seances Soc Biol Fil 1948 142 3–4 241 3 Search in Google Scholar

42 Alexander RF, Spriggs AI. The differential diagnosis of tumour cells in circulating blood. J Clin Pathol. 1960;13(5):414–24; DOI:10.1136/jcp.13.5.414. AlexanderRF SpriggsAI The differential diagnosis of tumour cells in circulating blood J Clin Pathol 1960 13 5 414 24 10.1136/jcp.13.5.414 48011113682365 Open DOISearch in Google Scholar

43 Budna J, Świerczewska M, Jankowiak A, Zabel M. Detekcja krążacych komórek nowotworowych przy zastosowaniu techniki EpiSPOT. Post Biol Komórki. 2015;42(3):401–16. BudnaJ ŚwierczewskaM JankowiakA ZabelM Detekcja krążacych komórek nowotworowych przy zastosowaniu techniki EpiSPOT Post Biol Komórki 2015 42 3 401 16 Search in Google Scholar

44 Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods. 1983;65(1–2):109–21; DOI:10.1016/0022-1759(83)90308-3. CzerkinskyCC NilssonLA NygrenH OuchterlonyO TarkowskiA A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells J Immunol Methods 1983 65 1–2 109 21 10.1016/0022-1759(83)90308-3 Open DOISearch in Google Scholar

45 Czerkinsky CC, Svennerholm AM. Ganglioside GM1 enzyme-linked immunospot assay for simple identification of heat-labile enterotoxin-producing Escherichia coli. J Clin Microbiol. 1983;17(6):965–69; DOI:10.1128/jcm.17.6.965-969.1983. CzerkinskyCC SvennerholmAM Ganglioside GM1 enzyme-linked immunospot assay for simple identification of heat-labile enterotoxin-producing Escherichia coli J Clin Microbiol 1983 17 6 965 69 10.1128/jcm.17.6.965-969.1983 2727846348080 Open DOISearch in Google Scholar

46 Xiong TF, Pan FQ, Li D. Expression and clinical significance of S100 family genes in patients with melanoma. Melanoma Res. 2019;29(1):23–9; DOI:10.1097/CMR.0000000000000512. XiongTF PanFQ LiD Expression and clinical significance of S100 family genes in patients with melanoma Melanoma Res 2019 29 1 23 9 10.1097/CMR.0000000000000512 631047230216200 Open DOISearch in Google Scholar

47 Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW. Tumour cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20): 6897–6904; DOI:10.1158/1078-0432.CCR-04-0378. AllardWJ MateraJ MillerMC RepolletM ConnellyMC RaoC TibbeAG UhrJW TerstappenLW Tumour cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases Clin Cancer Res 2004 10 20 6897 6904 10.1158/1078-0432.CCR-04-0378 15501967 Open DOISearch in Google Scholar

48 www.cellsearchruo.com/ruo-products/kits (dostęp: 18.11.2020). www.cellsearchruo.com/ruo-products/kits (dostęp: 18.11.2020). Search in Google Scholar

49 Garcia JG, Ma SF. Polymerase chain reaction: a landmark in the history of gene technology. Crit Care Med. 2005;33(12 Suppl):429–32; DOI:10.1097/01.ccm.0000186782.93865.00. GarciaJG MaSF Polymerase chain reaction: a landmark in the history of gene technology Crit Care Med 2005 33 12 Suppl 429 32 10.1097/01.ccm.0000186782.93865.00 16340413 Open DOISearch in Google Scholar

50 Green MR, Sambrook J. Analysis and Normalization of Real-Time Polymerase Chain Reaction (PCR) Experimental Data. Cold Spring Harb Protoc. 2018;2018(10); DOI:10.1101/pdb.top095000. GreenMR SambrookJ Analysis and Normalization of Real-Time Polymerase Chain Reaction (PCR) Experimental Data Cold Spring Harb Protoc 2018 2018 10 10.1101/pdb.top095000 30275081 Open DOISearch in Google Scholar

51 Bachman J. Reverse-transcription PCR (RT-PCR). Methods Enzymol. 2013;530:67–74; DOI:10.1016/B978-0-12-420037-1.00002-6. BachmanJ Reverse-transcription PCR (RT-PCR) Methods Enzymol 2013 530 67 74 10.1016/B978-0-12-420037-1.00002-6 24034314 Open DOISearch in Google Scholar

52 Hinz S, Hendricks A, Wittig A, Schafmayer C, Tepel J, Kalthoff H, Becker T, Röder C. Detection of circulating tumour cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study. BMC Cancer. 2017;17(1):53; DOI:10.1186/s12885-016-3035-1. HinzS HendricksA WittigA SchafmayerC TepelJ KalthoffH BeckerT RöderC Detection of circulating tumour cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study BMC Cancer 2017 17 1 53 10.1186/s12885-016-3035-1 523715828086834 Open DOISearch in Google Scholar

53 Ho-Pun-Cheung A, Bascoul-Mollevi C, Assenat E, Boissière-Michot F, Bibeau F, Cellier D, Ychou M, Lopez-Crapez E. Reverse transcription-quantitative polymerase chain reaction: description of a RIN-based algorithm for accurate data normalization. BMC Mol Biol. 2009; 10:31; DOI:10.1186/1471-2199-10-31. Ho-Pun-CheungA Bascoul-MolleviC AssenatE Boissière-MichotF BibeauF CellierD YchouM Lopez-CrapezE Reverse transcription-quantitative polymerase chain reaction: description of a RIN-based algorithm for accurate data normalization BMC Mol Biol 2009 10 31 10.1186/1471-2199-10-31 267974419368728 Open DOISearch in Google Scholar